Joan C Marini Selected Research

Collagen Type I (Type I Collagen)

1/2022	Dissecting the phenotypic variability of osteogenesis imperfecta.
1/2022	Osteogenesis Imperfecta: The Impact of Genotype and Clinical Phenotype on Adiposity and Resting Energy Expenditure.
1/2021	Targeting cellular stress in vitro improves osteoblast homeostasis, matrix collagen content and mineralization in two murine models of osteogenesis imperfecta.
1/2020	Substitution of murine type I collagen A1 3-hydroxylation site alters matrix structure but does not recapitulate osteogenesis imperfecta bone dysplasia.
1/2019	Longitudinal growth curves for children with classical osteogenesis imperfecta (types III and IV) caused by structural pathogenic variants in type I collagen.
5/2018	4-PBA ameliorates cellular homeostasis in fibroblasts from osteogenesis imperfecta patients by enhancing autophagy and stimulating protein secretion.
8/2017	Osteogenesis imperfecta.
1/2017	Cyclophilin B Deficiency Causes Abnormal Dentin Collagen Matrix.
4/2016	Cyclophilin-B Modulates Collagen Cross-linking by Differentially Affecting Lysine Hydroxylation in the Helical and Telopeptidyl Domains of Tendon Type I Collagen.
4/2016	Osteogenesis imperfecta.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joan C Marini Research Topics

Disease

55	Osteogenesis Imperfecta (Lobstein Disease) 01/2022 - 02/2003
8	Developmental Bone Diseases (Bone Dysplasia) 01/2022 - 01/2010
6	Osteoporosis 01/2020 - 06/2005
3	Type V Osteogenesis Imperfecta 01/2022 - 02/2015
3	Inborn Genetic Diseases (Disease, Hereditary) 03/2012 - 06/2007
3	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 04/2007 - 05/2005
2	type 6 Osteogenesis imperfecta 01/2022 - 06/2014
2	Melorheostosis 01/2020 - 08/2019
2	Pain (Aches) 08/2019 - 06/2005
2	Bone Diseases (Bone Disease) 01/2019 - 03/2007
2	Bone Fractures (Bone Fracture) 02/2015 - 01/2013
1	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2020
1	Contracture 01/2020
1	Sclerosteosis 12/2019
1	Type IX Osteogenesis Imperfecta 01/2017
1	type VIII Osteogenesis imperfecta 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2015
1	Alzheimer Disease (Alzheimer's Disease) 11/2015
1	Dehydration (Water Stress) 12/2012
1	Pulmonary Hypertension 08/2012
1	Pneumonia (Pneumonitis) 08/2012
1	Hypertrophy 08/2012
1	Hypoxia (Hypoxemia) 08/2012
1	Metabolic Bone Diseases (Osteopenia) 08/2010
1	Connective Tissue Diseases (Connective Tissue Disease) 07/2008
1	Autosomal Dominant Type VII Ehlers-Danlos Syndrome 03/2006

Drug/Important Bio-Agent (IBA)

33	Collagen Type I (Type I Collagen)IBA 01/2022 - 03/2003
29	CollagenIBA 01/2022 - 03/2003
19	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2006
9	Diphosphonates (Bisphosphonates)IBA 01/2018 - 06/2005
7	alpha2 Subunit Collagen Type IIBA 01/2020 - 01/2010
6	2-oxoglutarate 3-dioxygenase prolineIBA 01/2020 - 03/2007
5	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021 - 03/2003
4	InterferonsIBA 01/2020 - 08/2014
4	Procollagen Type IIBA 01/2019 - 02/2003
4	cyclophilin BIBA 04/2016 - 02/2010
3	pigment epithelium-derived factorIBA 01/2022 - 06/2014
2	MineralsIBA 09/2017 - 01/2016
2	Pamidronate (Aredia)FDA LinkGeneric 09/2017 - 06/2005
2	CalciumIBA 01/2017 - 01/2016
2	CationsIBA 01/2016 - 08/2014
2	HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA 08/2014 - 06/2011
2	IntegrinsIBA 07/2008 - 03/2007
1	4-phenylbutylamineIBA 05/2018
1	Lysine (L-Lysine)FDA Link 04/2016
1	NucleotidesIBA 01/2016
1	Codon (Codons)IBA 01/2016
1	PrionsIBA 11/2015
1	Flavin-Adenine Dinucleotide (FAD)IBA 11/2015
1	Prion ProteinsIBA 11/2015
1	Proline (L-Proline)FDA Link 11/2015
1	Presenilin-1IBA 11/2015
1	Cyclophilins (Cyclophilin)IBA 11/2015
1	Bone Morphogenetic Protein 1IBA 08/2014
1	Sp7 Transcription FactorIBA 08/2014
1	Biological ProductsIBA 12/2012
1	N-propionylprocainamideIBA 08/2012
1	Human Growth Hormone (Saizen)FDA LinkGeneric 06/2011
1	OsteocalcinIBA 08/2010
1	Peptides (Polypeptides)IBA 08/2010
1	Peptide Hormones (Polypeptide Hormones)IBA 08/2010
1	Carboxypeptidase H (Carboxypeptidase E)IBA 08/2010
1	Mixed Function Oxygenases (Monooxygenases)IBA 02/2010
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 05/2009
1	Cysteine (L-Cysteine)FDA Link 04/2007
1	Amino Acids FDA Link 04/2007
1	Proteoglycans (Proteoglycan)IBA 03/2007
1	Bone Density Conservation AgentsIBA 06/2005
1	Growth Hormone (Somatotropin)IBA 02/2003

Therapy/Procedure

9	Therapeutics 01/2020 - 02/2003
1	Palliative Care (Palliative Therapy) 08/2019
1	Operative Surgical Procedures 06/2011
1	Transplantation 07/2009